Bausch & Lomb files for its IPO; withdrawn after Valeant buys the company for $8.7bn

28 May 2013

Eye health company Bausch & Lomb Inc. has filed for its initial public offering.

Pharmaceuticals
Pharmaceuticals
- Generic Drugs
- OTC, Consumer
Medical Devices
- Diagnostic Equipment & Supplies
- Implantable Devices
- Laser
- Surgical Equipment & Devices

Already a Biomedtracker subscriber? You have access to the full deal record through your subscription

Want to become a subscriber? Subscribers get more deal details, updates, deal financials and deal products.

Questions?

Please contact Sales at: (212) 520-2765 or email [email protected]

Related Companies

Bausch & Lomb files for its IPO; withdrawn after Valeant buys the company for $8.7bn

All set! This article has been sent to my@email.address.

All fields are required. For multiple recipients, separate email addresses with a semicolon.

DCD.EmailPopout.Notice